Esperion Therapeutics, Inc. (ESPR) Stock Total Returns
Growth of $10,000 chart
2021-04-12 to 2026-04-10 to
$
%
%
Loading chart…
Investment Performance
Final Value
$834
Total Return
-91.66%
CAGR
-39.19%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.05% |
| Median | -4.24% |
| Best | +152.46% |
| Worst | -75.71% |
| % of Windows Positive | 43.6% |
1-Year (252 Trading Days)
| Average | -7.58% |
| Median | -24.66% |
| Best | +191.78% |
| Worst | -91.15% |
| % of Windows Positive | 42.2% |
3-Year (756 Trading Days)
| Average | -66.25% |
| Median | -70.11% |
| Best | +85.07% |
| Worst | -93.22% |
| % of Windows Positive | 2.6% |
Risk Metrics
| Maximum Drawdown | -97.46% |
| Average Drawdown | -82.83% |
| Drawdown Duration | 1244 Trading Days (Unrecovered) |
| Sortino Ratio | -0.12 |
| Calmar Ratio | -0.40 |
| CVaR (5%) | -12.61% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -41.35% (-85.76% ann.) | $4135.13 | $0.00 | $0.00 | $0.00 |
| 2025 | +68.18% | +$6818.17 | $0.00 | $0.00 | $0.00 |
| 2024 | -26.42% | $2642.15 | $0.00 | $0.00 | $0.00 |
| 2023 | -52.01% | $5200.64 | $0.00 | $0.00 | $0.00 |
| 2022 | +24.60% | +$2459.98 | $0.00 | $0.00 | $0.00 |
| 2021 | -80.77% | $8076.92 | $0.00 | $0.00 | $0.00 |
| 2020 | -56.40% | $5639.78 | $0.00 | $0.00 | $0.00 |
| 2019 | +29.63% | +$2963.04 | $0.00 | $0.00 | $0.00 |
| 2018 | -30.13% | $3013.36 | $0.00 | $0.00 | $0.00 |
| 2017 | +425.88% | +$42587.87 | $0.00 | $0.00 | $0.00 |
| 2016 | -43.76% | $4375.56 | $0.00 | $0.00 | $0.00 |
| 2015 | -44.96% | $4495.55 | $0.00 | $0.00 | $0.00 |
| 2014 | +194.32% | +$19432.32 | $0.00 | $0.00 | $0.00 |
| 2013 partial | -5.24% (-9.93% ann.) | $524.14 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 26, 2013 – February 19, 2020 | +386.48% | +26.86% | +$38648.28 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -47.70% | -99.94% | $4769.57 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -33.15% | -47.69% | $3314.80 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -68.73% | -66.81% | $6873.20 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -6.07% | -6.43% | $607.11 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -78.19% | -56.02% | $7818.62 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 10, 2026 | +24.71% | +15.23% | +$2471.25 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.